Clinical Trial Update: Minitransplants With HLA-matched Donors : Comparison Between 2 GVHD Prophylaxis Regimens [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update comparing two graft-versus-host disease prophylaxis regimens in minitransplants with HLA-matched donors for hematological malignan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Hematological Malignancies

Snippet

Sponsor: University of Liege | Conditions: Graft-Versus-Host Disease, Hematological Malignancies | Phase 2 | Status: ACTIVE_NOT_RECRUITING